CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 136 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $34 | -99.7% | 12,800 | +19.6% | 0.00% | +200.0% |
| Q1 2022 | $12,000 | +9.1% | 10,700 | -37.1% | 0.00% | – |
| Q4 2021 | $11,000 | +175.0% | 17,000 | +14.1% | 0.00% | – |
| Q3 2021 | $4,000 | +33.3% | 14,900 | +2.1% | 0.00% | – |
| Q2 2021 | $3,000 | -40.0% | 14,600 | -13.6% | 0.00% | – |
| Q1 2021 | $5,000 | +66.7% | 16,900 | +8.3% | 0.00% | – |
| Q4 2020 | $3,000 | 0.0% | 15,600 | +4.7% | 0.00% | – |
| Q3 2020 | $3,000 | -99.2% | 14,900 | -95.3% | 0.00% | -100.0% |
| Q2 2017 | $399,000 | +141.8% | 315,000 | 0.0% | 0.02% | +110.0% |
| Q1 2017 | $165,000 | – | 315,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 208,189 | $1,726,000 | 3.48% |
| FRIESS ASSOCIATES LLC | 571,940 | $4,741,000 | 2.53% |
| GABLES CAPITAL MANAGEMENT INC. | 438,764 | $3,637,000 | 2.28% |
| Prairiewood Capital, LLC | 258,073 | $2,139,000 | 1.50% |
| Quantedge Capital Pte Ltd | 597,300 | $4,952,000 | 1.46% |
| ARMISTICE CAPITAL, LLC | 8,372,000 | $69,404,000 | 1.34% |
| SummerHaven Investment Management, LLC | 158,473 | $1,314,000 | 0.74% |
| Capital Impact Advisors, LLC | 99,322 | $823,000 | 0.60% |
| EAM Investors, LLC | 365,415 | $3,029,000 | 0.56% |
| GLOBEFLEX CAPITAL L P | 304,515 | $2,524,000 | 0.51% |